Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Perry

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Neurology|March 1, 1979
Isoniazid therapy of Huntington diseaseT L Perry, J M Wright, S Hansen, et al.
Brain Research|April 1, 1985
Chronic treatment with ACTH1-24 does not produce permanent damage to the developing rat brainM Ito, V W Yong, T L Perry, et al.
Neurology|March 1, 1981
Neurotransmitter amino acids in dominantly inherited cerebellar disordersT L Perry, S J Kish, S Hansen, et al.
Journal of Neurochemistry|November 1, 1983
Neuronal [3H]benzodiazepine binding and levels of GABA, glutamate, and taurine are normal in Huntington's disease cerebellumS J Kish, K S Shannak, T L Perry, et al.
The New England Journal of Medicine|April 2, 1970
Glutamine depletion in phenylketonuria. A possible cause of the mental defectT L Perry, S Hansen, B Tischler, et al.
Journal of Neurochemistry|March 1, 1971
Regional distribution of amino acids in human brain obtained at autopsyT L Perry, K Berry, S Hansen, et al.
Journal of Neurochemistry|March 1, 1971
Free amino acids and related compounds in biopsies of human brainT L Perry, S Hansen, K Berry, et al.
Journal of Neurochemistry|March 1, 1982
Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's choreaT L Perry, S Hansen, R A Wall, et al.
Neuroscience Letters|October 8, 1986
Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouseT L Perry, V W Yong, K Jones, et al.
Neurology|March 1, 1991
Puppet-like syndrome of Angelman: a pathologic and neurochemical studyV Jay, L E Becker, F W Chan, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Neurology|March 1, 1979
Isoniazid therapy of Huntington diseaseT L Perry, J M Wright, S Hansen, et al.
Brain Research|April 1, 1985
Chronic treatment with ACTH1-24 does not produce permanent damage to the developing rat brainM Ito, V W Yong, T L Perry, et al.
Neurology|March 1, 1981
Neurotransmitter amino acids in dominantly inherited cerebellar disordersT L Perry, S J Kish, S Hansen, et al.
Journal of Neurochemistry|November 1, 1983
Neuronal [3H]benzodiazepine binding and levels of GABA, glutamate, and taurine are normal in Huntington's disease cerebellumS J Kish, K S Shannak, T L Perry, et al.
The New England Journal of Medicine|April 2, 1970
Glutamine depletion in phenylketonuria. A possible cause of the mental defectT L Perry, S Hansen, B Tischler, et al.
Journal of Neurochemistry|March 1, 1971
Regional distribution of amino acids in human brain obtained at autopsyT L Perry, K Berry, S Hansen, et al.
Journal of Neurochemistry|March 1, 1971
Free amino acids and related compounds in biopsies of human brainT L Perry, S Hansen, K Berry, et al.
Journal of Neurochemistry|March 1, 1982
Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's choreaT L Perry, S Hansen, R A Wall, et al.
Neuroscience Letters|October 8, 1986
Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouseT L Perry, V W Yong, K Jones, et al.
Neurology|March 1, 1991
Puppet-like syndrome of Angelman: a pathologic and neurochemical studyV Jay, L E Becker, F W Chan, et al.
Pageof 15